戻る Agenda
Session 4: Safety and Pharmacovigilance
Session Chair(s)
Sean Burke, MSC
(EFPIA IPVG Representative) Pharmacovigilance Lead, EEMEA, Merck , United Kingdom
Rachida Soulaymani-Benchei
Director, Centre Anti Poison Et De Pharmacovigilance Du Maroc, WHO Collaborative Center, Morocco
• WHO 3S Initiative and Continental Working Group on PV • North Africa updates on PV ? Tunisia: ? Algeria ? Morocco
Speaker(s)
Shanthi Pal, DRSC, MPHARM
Group Lead, Medicines Safety, Safety & Vigilance, WHO, Switzerland
WHO 3S Initiative: From Pilot to Programme – What Happens Beyond
Sarrah Kastalli
, Centre National de Pharmacovigilance, Tunisia
Nadjat LOUMI-MEDEDJEL
Responsible for Training of Healthcare Professionals and Staff, Centre National De Pharmacovigilance et De Matériovigilance (CNPM), Algeria
North Africa updates on PV: Algeria
Rachida Soulaymani-Benchei
Director, Centre Anti Poison Et De Pharmacovigilance Du Maroc, WHO Collaborative Center, Morocco
North Africa updates on PV: Morocco